You just read:

Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2019 American Psychiatric Association Annual Meeting

News provided by

Neurocrine Biosciences, Inc.

May 16, 2019, 16:01 ET